Literature DB >> 10632922

Immunohistochemical localization of the bone morphogenetic protein-6 in salivary pleomorphic adenomas.

K Kusafuka1, A Yamaguchi, T Kayano, T Takemura.   

Abstract

Salivary pleomorphic adenomas are often associated with chondroid tissue formation. We have found that bone morphogenetic proteins (BMP), especially BMP-2, may play an important role in ectopic chondrogenesis in this tumor. Bone morphogenetic protein-6 was reported to be related to the osteogenic metastasis of prostatic carcinomas. The relationship between BMP-6 expression and chondroid tissue formation is investigated. Twenty-three pleomorphic adenomas were examined immunohistochemically. The overexpression of BMP-6 was observed in 10 pleomorphic adenomas of the major salivary glands (43. 5%), and no evidence of BMP-6 expression in any of the nine pleomorphic adenomas of the palate. Bone morphogenetic protein-6 was immunolocalized in the lacuna cells of the chondroid tissue, in which type II collagen was localized. Bone morphogenetic protein-6 was expressed in inner ductal cells of the tubulo-glandular structures in the pleomorphic adenomas. This finding indicates that BMP-6 may be associated with the differentiation of inner ductal cells. Bone morphogenetic protein-6 was expressed weakly in neoplastic myoepithelial cells in the myxoid areas, which may be related to the production of extracellular matrices. Bone morphogenetic protein-6 has a role in chondroid formation, and also tubulo-glandular differentiation in pleomorphic adenomas. In conclusion, a large portion of pleomorphic adenomas of the salivary gland origin, but not of palate origin, was shown to overexpress BMP-6 protein.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10632922     DOI: 10.1046/j.1440-1827.1999.00991.x

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  7 in total

Review 1.  The Yin and Yang of bone morphogenetic proteins in cancer.

Authors:  Ashok Singh; Rebecca J Morris
Journal:  Cytokine Growth Factor Rev       Date:  2010-08-04       Impact factor: 7.638

2.  Cartilage-specific matrix protein chondromodulin-I is associated with chondroid formation in salivary pleomorphic adenomas: immunohistochemical analysis.

Authors:  K Kusafuka; Y Hiraki; C Shukunami; A Yamaguchi; T Kayano; T Takemura
Journal:  Am J Pathol       Date:  2001-04       Impact factor: 4.307

3.  Immunohistochemical evaluation of cartilage-derived morphogenic protein-1 and -2 in normal human salivary glands and pleomorphic adenomas.

Authors:  Kimihide Kusafuka; Franck P Luyten; Raymond De Bondt; Yuji Hiraki; Chisa Shukunami; Teruo Kayano; Tamiko Takemura
Journal:  Virchows Arch       Date:  2003-04-18       Impact factor: 4.064

4.  Ultrastructural immunolocalization of a cartilage-specific proteoglycan, aggrecan, in salivary pleomorphic adenomas.

Authors:  Koji Muramatsu; Kimihide Kusafuka; Hideto Watanabe; Toru Mochizuki; Takashi Nakajima
Journal:  Med Mol Morphol       Date:  2009-03-18       Impact factor: 2.309

5.  Expression and localization of cartilage-specific matrix protein chondromodulin-I mRNA in salivary pleomorphic adenomas.

Authors:  Kimihide Kusafuka; Keisuke Nakano; Yuji Hiraki; Chisa Shukunami; Hitoshi Nagatsuka; Noriyuki Nagai; Tamiko Takemura; Yutaku Sakaguchi; Kazuichi Okazaki; Michi Kusafuka; Hiroko Hisha; Susumu Ikehara
Journal:  Virchows Arch       Date:  2004-11-11       Impact factor: 4.064

6.  BMP-6 promotes E-cadherin expression through repressing deltaEF1 in breast cancer cells.

Authors:  Shuang Yang; Jun Du; Zhaoqi Wang; Wei Yuan; Yuhuan Qiao; Ming Zhang; Jie Zhang; Songyuan Gao; Jian Yin; Baocun Sun; Tianhui Zhu
Journal:  BMC Cancer       Date:  2007-11-13       Impact factor: 4.430

7.  Wnt signaling as a possible promoting factor of cell differentiation in pleomorphic adenomas.

Authors:  Yukiko Okuda; Keisuke Nakano; Koji Suzuki; Yoshihiko Sugita; Katsutoshi Kubo; Hatsuhiko Maeda; Norimasa Okafuji; Hiromasa Hasegawa; Toshiyuki Kawakami
Journal:  Int J Med Sci       Date:  2014-07-10       Impact factor: 3.738

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.